The US Food and Drug Administration (FDA) has awarded orphan drug designation (ODD) to AstraZeneca’s Imfinzi (durvalumab) in small cell...
Read More...
The post AstraZeneca’s Imfinzi cancer drug secures orphan status in US appeared first on Pharmaceutical Technology.
Original Article: AstraZeneca’s Imfinzi cancer drug secures orphan status in US